INVESTORS

Invest in a more responsible future for sexual health

KOOPLA is developing a privacy-focused platform that helps people notify previous sexual partners anonymously following an STI diagnosis. Our goal is to make responsible communication easier, reduce stigma and encourage earlier testing.

Contact the KOOPLA Team

CONNECT.
PROTECT.
RESPECT.

A growing public- and digital health opportunity

Sexually transmitted infections remain a significant and growing public-health challenge. KOOPLA is being developed to address the communication gap through a private, accessible and scalable digital solution.

Privacy by Design
Data minimisation, anonymity and European data-protection principles.

Scalable Technology
A mobile-first product supported by cloud infrastructure and designed for multiple European markets.

Clear Social Impact
Supporting earlier testing, responsible communication and reduced stigma.

European Growth Potential
Initial launch planned for Spain, followed by additional European markets.

Where we are today

● Completed

◐ In progress

○ Planned

●

Concept developed

●

Market research

●

User feedback

◐

Prototype created

○

Development preparation

○

Beta launch

○

Public launch

Strategic capital and long-term partners

KOOPLA is interested in speaking with investors and strategic partners who understand digital health, privacy-focused technology and mission-driven growth.

Angel investors · Health-tech investors · Early-stage venture capital · Strategic corporate partners · Public innovation and grant partners

Investment would support product development, legal and regulatory preparation, technical infrastructure, market launch and future European expansion.

Confidential materials available on request

Our investor presentation, business plan, market research and financial planning documents are shared directly with qualified investors and strategic partners.

Request Access

Patern

KOOPLA is developing a layered intellectual-property strategy designed to protect its brand, technology and long-term commercial position. The KOOPLA™ name has been approved and registered as a European Union trade mark by the European Union Intellectual Property Office (EUIPO), application No. [INSERT NUMBER]. Further territorial protection will be considered in line with KOOPLA’s planned international expansion.

Request Access

Let’s Start a Conversation

We welcome conversations with investors and strategic partners who share our ambition to improve sexual-health communication through privacy-focused technology.

Investor contact: investors@koopla.org